Novato, CA, United States of America

Sharyl Fyffe-Maricich

USPTO Granted Patents = 2 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):

Title: Sharyl Fyffe-Maricich: Innovator in Creatine Prodrugs

Introduction

Sharyl Fyffe-Maricich is a notable inventor based in Novato, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of creatine prodrugs. With a total of two patents to her name, her work focuses on addressing creatine deficiencies through innovative compositions and methods.

Latest Patents

Sharyl's latest patents include "Creatine prodrugs, compositions and methods of use thereof." This patent provides creatine prodrug analogs and their compositions that are useful for the treatment of creatine deficiencies. The innovative approach aims to enhance the therapeutic potential of creatine, offering new solutions for individuals suffering from related health issues.

Career Highlights

Sharyl is currently associated with Ultragenyx Pharmaceutical Inc., where she continues to advance her research and development efforts. Her work at this company underscores her commitment to improving patient outcomes through innovative pharmaceutical solutions.

Collaborations

Throughout her career, Sharyl has collaborated with esteemed colleagues, including Yiumo Chan and Emil D Kakkis. These partnerships have played a crucial role in her research endeavors and have contributed to the success of her projects.

Conclusion

Sharyl Fyffe-Maricich is a pioneering inventor whose work in creatine prodrugs has the potential to make a significant impact in the treatment of creatine deficiencies. Her contributions to the pharmaceutical industry highlight the importance of innovation in addressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…